Company attributes
Location
Pitchbook URL
Legal Name
Aprea Therapeutics, Inc.
Number of Employees (Ranges)
11 – 50
Email Address
info@aprea.com
Phone Number
+16174639385
Full Address
535 Boylston St. Boston, MA 02116 USA
3805 Old Easton Rd. Doylestown, PA 18902 USA
Nobels väg 16 SE-171 65 Solna, Sweden
CIK Number
Place of Incorporation
Investors
Founded Date
2003
Total Funding Amount (USD)
113,600,000
Latest Funding Round Date
2018
Stock Symbol
APRE
Exchange
Board of Directors
Also Known As
Aprea Therapeutics
Latest Funding Type
Country
Headquarters
Other attributes
Acquired Company
Company Operating Status
Active
Contact Page URL
Latest Funding Round Amount (USD)
57,000,000
SIC Code
2,834
Ticker Symbol
APRE
Aprea Therapeutics Inc., (NASDAQ: APRE) is a biopharmaceutical company headquartered in Boston, Massachusetts with research facilities in Stockholm, Sweden, focused on developing and commercializing novel cancer therapeutics to reactivate the mutant tumor suppressor protein p53, the most commonly mutated gene in cancer.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
